Etopósido

Etopósido is a medicine known commercially as Vepesid or Etosin.

This medicine for oral and injectable use is an antineoplastic, indicated for the treatment of individuals with lung and testicular cancer.

Indications of Etopósido

Lung cancer; testicular cancer; leukemia; Hodkin's disease.

Side effects of Etopósido

Low pressure; diarrhea; nausea; vomiting; lack of appetite; decrease in white blood cells; decreased blood platelets; anemia; hair loss.

Contraindications for Etopósido

Pregnancy risk D; Lactating women; Hipersensibility to any of the formula's components.

How to use Etopósido

Oral use

Adults

• Lung cancer: Administer 70 mg per m² of body surface daily for 4 consecutive days. Repeat the process every 3 to 4 weeks.

Injectable use (intravenous)

• Lung cancer: Inject 35 mg per m² of body surface daily for 4 days. Repeat the procedure every 3 to 4 weeks. Testicular cancer: Inject 50 to 100 mg per m² of body surface daily. Repeat the procedure for 3 to 4 weeks.